[The significance of the erythrocyte antioxidant system in the development of anemia in hemoblastosis patients].
Petukhov
V I
VI
Iansons
E
E
Bondare
D K
DK
Toma
A
A
Shkesteris
A
A
Kumerova
A
A
Rastrigin
V L
VL
Demidova
A V
AV
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D000975:Antioxidants; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007938:Leukemia / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D015227:Lipid Peroxidation / Q000187:drug effects; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D013482:Superoxide Dismutase / Q000097:blood / Q000187:drug effects
D000975:Antioxidants; D008315:Malondialdehyde; D013482:Superoxide Dismutase
O znachenii antioksidantnoĭ sistemy éritrotsitov v razvitii anemii u bol'nykh gemoblastozami.